5-90474093-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_203406.2(MBLAC2):āc.200A>Gā(p.Glu67Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000698 in 1,574,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_203406.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MBLAC2 | NM_203406.2 | c.200A>G | p.Glu67Gly | missense_variant | 1/2 | ENST00000316610.7 | NP_981951.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBLAC2 | ENST00000316610.7 | c.200A>G | p.Glu67Gly | missense_variant | 1/2 | 1 | NM_203406.2 | ENSP00000314776.6 | ||
MBLAC2 | ENST00000514906.1 | c.200A>G | p.Glu67Gly | missense_variant | 1/1 | 6 | ENSP00000425600.1 | |||
POLR3G | ENST00000505345.5 | c.-269T>C | 5_prime_UTR_variant | 1/4 | 3 | ENSP00000427412.1 | ||||
POLR3G | ENST00000512239.1 | c.-44+2167T>C | intron_variant | 5 | ENSP00000424970.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000437 AC: 8AN: 182962Hom.: 0 AF XY: 0.0000407 AC XY: 4AN XY: 98200
GnomAD4 exome AF: 0.00000492 AC: 7AN: 1422808Hom.: 0 Cov.: 36 AF XY: 0.00000568 AC XY: 4AN XY: 704026
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74292
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at